Human disease
colorectal cancer
Mondo defines it as: “A primary or metastatic malignant neoplasm that affects the colon or rectum. Representative examples include carcinoma, lymphoma, and sarcoma.”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 1990 | Cancer, TP53-related | OMIA's OMIM numbers | 5 | Drug |
83.3
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
| Human gene | Score | Evidence |
|---|---|---|
| TP53 | 0.75 | 4,421 |
| KRAS | 0.53 | 5,006 |
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Aflibercept | None of these genes | Approved |
| Anamorelin | None of these genes | Approved |
| Bevacizumab | None of these genes | Approved |
| Capecitabine | None of these genes | Approved |
| Cetuximab | None of these genes | Approved |
| Edrecolomab | None of these genes | Approved |
| Floxuridine | None of these genes | Approved |
| Fruquintinib | None of these genes | Approved |
| Irinotecan | None of these genes | Approved |
| Levoleucovorin | None of these genes | Approved |
| Necitumumab | None of these genes | Approved |
| Nintedanib | None of these genes | Approved |
| Oxaliplatin | None of these genes | Approved |
| Panitumumab | None of these genes | Approved |
| Regorafenib | None of these genes | Approved |
| Technetium | None of these genes | Approved |
| Tipiracil | None of these genes | Approved |
| Trifluridine | None of these genes | Approved |
| Votumumab | None of these genes | Approved |
| Adagrasib | KRAS | Phase 3 |
| Adebrelimab | None of these genes | Phase 3 |
| Amivantamab | None of these genes | Phase 3 |
| Arfolitixorin | None of these genes | Phase 3 |
| Ascorbic Acid | None of these genes | Phase 3 |
| Aspirin | None of these genes | Phase 3 |
| Atezolizumab | None of these genes | Phase 3 |
| Becotatug | None of these genes | Phase 3 |
| Bermekimab | None of these genes | Phase 3 |
| Cadonilimab | None of these genes | Phase 3 |
| Catequentinib | None of these genes | Phase 3 |
| Cediranib | None of these genes | Phase 3 |
| Celecoxib | None of these genes | Phase 3 |
| Cholecalciferol | None of these genes | Phase 3 |
| Cisplatin | None of these genes | Phase 3 |
| Cyclosporine | None of these genes | Phase 3 |
| Dalteparin Sodium | None of these genes | Phase 3 |
| Dexamethasone | None of these genes | Phase 3 |
| Doxorubicin | None of these genes | Phase 3 |
| Encorafenib | None of these genes | Phase 3 |
| Endostatin, N-Terminal-Mggshhhhh | None of these genes | Phase 3 |
| Eniluracil | None of these genes | Phase 3 |
| Erlotinib | None of these genes | Phase 3 |
| Exisulind | None of these genes | Phase 3 |
| Favezelimab | None of these genes | Phase 3 |
| Fish Oil | None of these genes | Phase 3 |
| Fluorouracil | None of these genes | Phase 3 |
| Folinic Acid | None of these genes | Phase 3 |
| Gimeracil | None of these genes | Phase 3 |
| Interferon Alfa | None of these genes | Phase 3 |
| Ipatasertib | None of these genes | Phase 3 |
| Ipilimumab | None of these genes | Phase 3 |
| Ivonescimab | None of these genes | Phase 3 |
| Lefitolimod | None of these genes | Phase 3 |
| Lenvatinib | None of these genes | Phase 3 |
| Leucovorin | None of these genes | Phase 3 |
| Levamisole | None of these genes | Phase 3 |
| Lidocaine | None of these genes | Phase 3 |
| Loperamide | None of these genes | Phase 3 |
| Magnesium Citrate | None of these genes | Phase 3 |
| Masitinib | None of these genes | Phase 3 |
| Mebendazole | None of these genes | Phase 3 |
| Melphalan | None of these genes | Phase 3 |
| Metformin | None of these genes | Phase 3 |
| Methylprednisolone | None of these genes | Phase 3 |
| Mitomycin | None of these genes | Phase 3 |
| Morphine | None of these genes | Phase 3 |
| Napabucasin | None of these genes | Phase 3 |
| Nimotuzumab | None of these genes | Phase 3 |
| Nitazoxanide | None of these genes | Phase 3 |
| Nivolumab | None of these genes | Phase 3 |
| Octreotide | None of these genes | Phase 3 |
| Olaparib | None of these genes | Phase 3 |
| Omega-3 Fatty Acids | None of these genes | Phase 3 |
| Omeprazole | None of these genes | Phase 3 |
| Pembrolizumab | None of these genes | Phase 3 |
| Perifosine | None of these genes | Phase 3 |
| Picoplatin | None of these genes | Phase 3 |
| Picosulfuric Acid | None of these genes | Phase 3 |
| Polyethylene Glycol | None of these genes | Phase 3 |
| Polyethylene Glycol 3350 | None of these genes | Phase 3 |
| Precemtabart Tocentecan | None of these genes | Phase 3 |
| Propofol | None of these genes | Phase 3 |
| Pucotenlimab | None of these genes | Phase 3 |
| Raltitrexed | None of these genes | Phase 3 |
| Ramucirumab | None of these genes | Phase 3 |
| Rivoceranib | None of these genes | Phase 3 |
| Ropivacaine | None of these genes | Phase 3 |
| S1? | None of these genes | Phase 3 |
| Semaxanib | None of these genes | Phase 3 |
| Sevoflurane | None of these genes | Phase 3 |
| Silymarin | None of these genes | Phase 3 |
| Simvastatin | None of these genes | Phase 3 |
| Sintilimab | None of these genes | Phase 3 |
| Sorafenib | None of these genes | Phase 3 |
| Sotorasib | KRAS | Phase 3 |
| Sulfasalazine | None of these genes | Phase 3 |
| Sunitinib | None of these genes | Phase 3 |
| Suvemcitug | None of these genes | Phase 3 |
| Talaporfin | None of these genes | Phase 3 |
| Tegafur | None of these genes | Phase 3 |
| Telisotuzumab Adizutecan | None of these genes | Phase 3 |
| Thalidomide | None of these genes | Phase 3 |
| Thymalfasin | None of these genes | Phase 3 |
| Tislelizumab | None of these genes | Phase 3 |
| Trabedersen | None of these genes | Phase 3 |
| Trastuzumab | None of these genes | Phase 3 |
| Trastuzumab Rezetecan | None of these genes | Phase 3 |
| Tucatinib | None of these genes | Phase 3 |
| Tucidinostat | None of these genes | Phase 3 |
| Tunlametinib | None of these genes | Phase 3 |
| Uracil | None of these genes | Phase 3 |
| Vatalanib | None of these genes | Phase 3 |
| Vemurafenib | None of these genes | Phase 3 |
| Charcoal, Activated | None of these genes | Phase 2/3 |
| Endostatin | None of these genes | Phase 2/3 |
| Enlonstobart | None of these genes | Phase 2/3 |
| Heparin | None of these genes | Phase 2/3 |
| Indocyanine Green Acid Form | None of these genes | Phase 2/3 |
| Lutadenovec Autogene | None of these genes | Phase 2/3 |
| Sacituzumab Govitecan | None of these genes | Phase 2/3 |
| Sapecmeran Autogene | None of these genes | Phase 2/3 |
| 1-(4-(Dimethylamino)Piperidin-1-Yl)-3-Hydroxy-3-(1-Methyl-1h-Imidazol-2-Yl)Propan-1-One, (S)- | None of these genes | Phase 2 |
| 6-O-Benzylguanine | None of these genes | Phase 2 |
| 7-Ethyl-10-Hydroxycamptothecin | None of these genes | Phase 2 |
| Abemaciclib | None of these genes | Phase 2 |
| Abituzumab | None of these genes | Phase 2 |
| Afatinib | None of these genes | Phase 2 |
| Aldesleukin | None of these genes | Phase 2 |
| Alectinib | None of these genes | Phase 2 |
| Alpelisib | None of these genes | Phase 2 |
| Anakinra | None of these genes | Phase 2 |
| Andrographolide | None of these genes | Phase 2 |
| Anpocogin | None of these genes | Phase 2 |
| Antimony | None of these genes | Phase 2 |
| Aroplatin | None of these genes | Phase 2 |
| Artesunate | None of these genes | Phase 2 |
| Autogene Cevumeran | None of these genes | Phase 2 |
| Avelumab | None of these genes | Phase 2 |
| Aviscumine | None of these genes | Phase 2 |
| Avutometinib | None of these genes | Phase 2 |
| Axitinib | None of these genes | Phase 2 |
| Azacitidine | None of these genes | Phase 2 |
| Bafisontamab | None of these genes | Phase 2 |
| Balstilimab | None of these genes | Phase 2 |
| Becatecarin | None of these genes | Phase 2 |
| Becotatug Vedotin | None of these genes | Phase 2 |
| Belzutifan | None of these genes | Phase 2 |
| Binimetinib | None of these genes | Phase 2 |
| Bleomycin | None of these genes | Phase 2 |
| Bms-986310 | None of these genes | Phase 2 |
| Bortezomib | None of these genes | Phase 2 |
| Botensilimab | None of these genes | Phase 2 |
| Brivanib | None of these genes | Phase 2 |
| Bryostatin 1 | None of these genes | Phase 2 |
| Cabazitaxel | None of these genes | Phase 2 |
| Cabozantinib | None of these genes | Phase 2 |
| Calcium | None of these genes | Phase 2 |
| Camrelizumab | None of these genes | Phase 2 |
| Cannabidiol | None of these genes | Phase 2 |
| Carboplatin | None of these genes | Phase 2 |
| Carmustine | None of these genes | Phase 2 |
| Cemiplimab | None of these genes | Phase 2 |
| Cetuximab Beta | None of these genes | Phase 2 |
| Chlorsulfaquinoxaline | None of these genes | Phase 2 |
| Ciprofloxacin | None of these genes | Phase 2 |
| Cixutumumab | None of these genes | Phase 2 |
| Clobetasol Propionate | None of these genes | Phase 2 |
| Cobimetinib | None of these genes | Phase 2 |
| Conatumumab | None of these genes | Phase 2 |
| Cpi 613 | None of these genes | Phase 2 |
| Crizotinib | None of these genes | Phase 2 |
| Curcumin | None of these genes | Phase 2 |
| Cyclophosphamide Anhydrous | None of these genes | Phase 2 |
| Dabrafenib | None of these genes | Phase 2 |
| Dalotuzumab | None of these genes | Phase 2 |
| Dalpiciclib | None of these genes | Phase 2 |
| Danvatirsen | None of these genes | Phase 2 |
| Daratumumab | None of these genes | Phase 2 |
| Dasatinib Anhydrous | None of these genes | Phase 2 |
| Datopotamab Deruxtecan | None of these genes | Phase 2 |
| Davanat | None of these genes | Phase 2 |
| Decitabine | None of these genes | Phase 2 |
| Defactinib | None of these genes | Phase 2 |
| Denenicokin | None of these genes | Phase 2 |
| Denikitug | None of these genes | Phase 2 |
| Desmopressin | None of these genes | Phase 2 |
| Dilpacimab | None of these genes | Phase 2 |
| Disitamab Vedotin | None of these genes | Phase 2 |
| Dkn-01 | None of these genes | Phase 2 |
| Docetaxel Anhydrous | None of these genes | Phase 2 |
| Domatinostat | None of these genes | Phase 2 |
| Dostarlimab | None of these genes | Phase 2 |
| Dovitinib | None of these genes | Phase 2 |
| Duligotuzumab | None of these genes | Phase 2 |
| Durvalumab | None of these genes | Phase 2 |
| E-7820 | None of these genes | Phase 2 |
| Ecadotril | None of these genes | Phase 2 |
| Efatutazone | None of these genes | Phase 2 |
| Elacytarabine | None of these genes | Phase 2 |
| Eliglustat | None of these genes | Phase 2 |
| Elraglusib | None of these genes | Phase 2 |
| Enfortumab Vedotin | None of these genes | Phase 2 |
| Ensituximab | None of these genes | Phase 2 |
| Entinostat | None of these genes | Phase 2 |
| Entolimod | None of these genes | Phase 2 |
| Entrectinib | None of these genes | Phase 2 |
| Envafolimab | None of these genes | Phase 2 |
| Enzastaurin | None of these genes | Phase 2 |
| Epothilone D | None of these genes | Phase 2 |
| Erfonrilimab | None of these genes | Phase 2 |
| Ethiodized Oil | None of these genes | Phase 2 |
| Etirinotecan Pegol | None of these genes | Phase 2 |
| Etirinotecan Pegol Tetrahydrochloride | None of these genes | Phase 2 |
| Etirinotecan Pegol Tetratriflutate | None of these genes | Phase 2 |
| Everolimus | None of these genes | Phase 2 |
| Evorpacept | None of these genes | Phase 2 |
| Famitinib | None of these genes | Phase 2 |
| Ferric Carboxymaltose | None of these genes | Phase 2 |
| Ferric Derisomaltose | None of these genes | Phase 2 |
| Ferric Oxyhydroxide | None of these genes | Phase 2 |
| Ferrous Sulfate | None of these genes | Phase 2 |
| Fianlimab | None of these genes | Phase 2 |
| Filgrastim | None of these genes | Phase 2 |
| Fludarabine | None of these genes | Phase 2 |
| Fluzoparib | None of these genes | Phase 2 |
| Folic Acid | None of these genes | Phase 2 |
| Folitixorin | None of these genes | Phase 2 |
| Fosifloxuridine Nafalbenamide | None of these genes | Phase 2 |
| Futibatinib | None of these genes | Phase 2 |
| Futuximab | None of these genes | Phase 2 |
| G17dt Immunogen | None of these genes | Phase 2 |
| Ganetespib | None of these genes | Phase 2 |
| Gedatolisib | None of these genes | Phase 2 |
| Gefitinib | None of these genes | Phase 2 |
| Gemcitabine | None of these genes | Phase 2 |
| Gilvetmab | None of these genes | Phase 2 |
| Glp-1 | None of these genes | Phase 2 |
| Gossypol Acetic Acid | None of these genes | Phase 2 |
| Hepatitis B Virus Hbsag Surface Protein Antigen | None of these genes | Phase 2 |
| Hiltonol | None of these genes | Phase 2 |
| Hydroxychloroquine | None of these genes | Phase 2 |
| Icosapent Ethyl | None of these genes | Phase 2 |
| Icrucumab | None of these genes | Phase 2 |
| Idelalisib | None of these genes | Phase 2 |
| Ign-101 | None of these genes | Phase 2 |
| Imalumab | None of these genes | Phase 2 |
| Imatinib | None of these genes | Phase 2 |
| Imgatuzumab | None of these genes | Phase 2 |
| Imzokitug | None of these genes | Phase 2 |
| Inavolisib | None of these genes | Phase 2 |
| Indisulam | None of these genes | Phase 2 |
| Influenza A Virus, Split Virion | None of these genes | Phase 2 |
| Influenza Virus Vaccine | None of these genes | Phase 2 |
| Interferon Alfa-2a | None of these genes | Phase 2 |
| Interferon Alfa-2b | None of these genes | Phase 2 |
| Interleukin-7 | None of these genes | Phase 2 |
| Irofulven | None of these genes | Phase 2 |
| Iron Isomaltoside 1000 | None of these genes | Phase 2 |
| Isis-2503 | None of these genes | Phase 2 |
| Ispinesib | None of these genes | Phase 2 |
| Isunakinra | None of these genes | Phase 2 |
| Ivosidenib | None of these genes | Phase 2 |
| Ixabepilone | None of these genes | Phase 2 |
| Izalontamab | None of these genes | Phase 2 |
| Kn-026 | None of these genes | Phase 2 |
| Labetuzumab | None of these genes | Phase 2 |
| Labetuzumab Govitecan | None of these genes | Phase 2 |
| Lamivudine | None of these genes | Phase 2 |
| Lapatinib | None of these genes | Phase 2 |
| Lapuleucel-T | None of these genes | Phase 2 |
| Larotrectinib | None of these genes | Phase 2 |
| Leflunomide | None of these genes | Phase 2 |
| Lenalidomide | None of these genes | Phase 2 |
| Leronlimab | None of these genes | Phase 2 |
| Levocetirizine | None of these genes | Phase 2 |
| Linaclotide | None of these genes | Phase 2 |
| Linifanib | None of these genes | Phase 2 |
| Litronesib | None of these genes | Phase 2 |
| Lobaplatin | None of these genes | Phase 2 |
| Lomustine | None of these genes | Phase 2 |
| Lorigerlimab | None of these genes | Phase 2 |
| Magrolimab | None of these genes | Phase 2 |
| Methotrexate | None of these genes | Phase 2 |
| Metronidazole | None of these genes | Phase 2 |
| Milataxel | None of these genes | Phase 2 |
| Mirabegron | None of these genes | Phase 2 |
| Mk-2206 | None of these genes | Phase 2 |
| Molgramostim | None of these genes | Phase 2 |
| Molibresib | None of these genes | Phase 2 |
| Monalizumab | None of these genes | Phase 2 |
| Murlentamab | None of these genes | Phase 2 |
| Muzastotug | None of these genes | Phase 2 |
| Nanrilkefusp Alfa | None of these genes | Phase 2 |
| Navarixin Anhydrous | None of these genes | Phase 2 |
| Navicixizumab | None of these genes | Phase 2 |
| Nibrozetone | None of these genes | Phase 2 |
| Niclosamide | None of these genes | Phase 2 |
| Niraparib | None of these genes | Phase 2 |
| Nisevokitug | None of these genes | Phase 2 |
| Novaferon | None of these genes | Phase 2 |
| Ofranergene Obadenovec | None of these genes | Phase 2 |
| Oglufanide | None of these genes | Phase 2 |
| Oleclumab | None of these genes | Phase 2 |
| Ompenaclid | None of these genes | Phase 2 |
| Onartuzumab | None of these genes | Phase 2 |
| Ongericimab | None of these genes | Phase 2 |
| Ontuxizumab | None of these genes | Phase 2 |
| Onvansertib | None of these genes | Phase 2 |
| Oteracil | None of these genes | Phase 2 |
| Oxazolidine | None of these genes | Phase 2 |
| Paclitaxel | None of these genes | Phase 2 |
| Pacritinib | None of these genes | Phase 2 |
| Palbociclib | None of these genes | Phase 2 |
| Panobinostat | None of these genes | Phase 2 |
| Parsatuzumab | None of these genes | Phase 2 |
| Patritumab Deruxtecan | None of these genes | Phase 2 |
| Patupilone | None of these genes | Phase 2 |
| Pegdinetanib | None of these genes | Phase 2 |
| Pegenzileukin | None of these genes | Phase 2 |
| Pegfilgrastim | None of these genes | Phase 2 |
| Peginterferon Alfa-2a | None of these genes | Phase 2 |
| Pelareorep | None of these genes | Phase 2 |
| Pelitinib | None of these genes | Phase 2 |
| Pelitrexol | None of these genes | Phase 2 |
| Pemetrexed | None of these genes | Phase 2 |
| Pemigatinib | None of these genes | Phase 2 |
| Penpulimab | None of these genes | Phase 2 |
| Pertuzumab | None of these genes | Phase 2 |
| Pexastimogene Devacirepvec | None of these genes | Phase 2 |
| Pimasertib | None of these genes | Phase 2 |
| Pimurutamab | None of these genes | Phase 2 |
| Pirfenidone | None of these genes | Phase 2 |
| Plocabulin | None of these genes | Phase 2 |
| Poziotinib | None of these genes | Phase 2 |
| Prednisone | None of these genes | Phase 2 |
| Pregabalin | None of these genes | Phase 2 |
| Pri-724 | None of these genes | Phase 2 |
| Prolgolimab | None of these genes | Phase 2 |
| Propranolol | None of these genes | Phase 2 |
| Pyrazoloacridine | None of these genes | Phase 2 |
| Pyrimidine | None of these genes | Phase 2 |
| Pyrotinib | None of these genes | Phase 2 |
| Quavonlimab | None of these genes | Phase 2 |
| Regramostim | None of these genes | Phase 2 |
| Relatlimab | None of these genes | Phase 2 |
| Resveratrol | None of these genes | Phase 2 |
| Retinol | None of these genes | Phase 2 |
| Retlirafusp Alfa | None of these genes | Phase 2 |
| Rg-4733 | None of these genes | Phase 2 |
| Rilvegostomig | None of these genes | Phase 2 |
| Rimegepant | None of these genes | Phase 2 |
| Rintatolimod | None of these genes | Phase 2 |
| Robatumumab | None of these genes | Phase 2 |
| Romidepsin | None of these genes | Phase 2 |
| Romiplostim | None of these genes | Phase 2 |
| Rubitecan | None of these genes | Phase 2 |
| Ruxolitinib | None of these genes | Phase 2 |
| Sapitinib | None of these genes | Phase 2 |
| Saracatinib | None of these genes | Phase 2 |
| Sarcnu | None of these genes | Phase 2 |
| Sargramostim | None of these genes | Phase 2 |
| Savolitinib | None of these genes | Phase 2 |
| Sc-0191 | None of these genes | Phase 2 |
| Selinexor | None of these genes | Phase 2 |
| Selumetinib | None of these genes | Phase 2 |
| Semaglutide | None of these genes | Phase 2 |
| Seribantumab | None of these genes | Phase 2 |
| Serplulimab | None of these genes | Phase 2 |
| Sibrotuzumab | None of these genes | Phase 2 |
| Simtuzumab | None of these genes | Phase 2 |
| Simurosertib | None of these genes | Phase 2 |
| Sotevtamab | None of these genes | Phase 2 |
| Spartalizumab | None of these genes | Phase 2 |
| Sph-5030 | None of these genes | Phase 2 |
| Streptococcus Pneumoniae Polysaccharide Conjugated To Corynebacterium Diphtheriae Crm197 | None of these genes | Phase 2 |
| Sulindac | None of these genes | Phase 2 |
| Surufatinib | None of these genes | Phase 2 |
| Tadalafil | None of these genes | Phase 2 |
| Talazoparib | None of these genes | Phase 2 |
| Tas-109 | None of these genes | Phase 2 |
| Tazemetostat | None of these genes | Phase 2 |
| Temozolomide | None of these genes | Phase 2 |
| Temsirolimus | None of these genes | Phase 2 |
| Tepotinib | None of these genes | Phase 2 |
| Teriparatide | None of these genes | Phase 2 |
| Terlipressin | None of these genes | Phase 2 |
| Tetanus Toxoid | None of these genes | Phase 2 |
| Tezacitabine Anhydrous | None of these genes | Phase 2 |
| Tigatuzumab | None of these genes | Phase 2 |
| Tinodasertib | None of these genes | Phase 2 |
| Tipifarnib | None of these genes | Phase 2 |
| Tiragolumab | None of these genes | Phase 2 |
| Tirapazamine | None of these genes | Phase 2 |
| Tisotumab Vedotin | None of these genes | Phase 2 |
| Tivantinib | None of these genes | Phase 2 |
| Tivozanib | None of these genes | Phase 2 |
| Tk-112690 | None of these genes | Phase 2 |
| Tocotrienol | None of these genes | Phase 2 |
| Tomivosertib | None of these genes | Phase 2 |
| Topotecan | None of these genes | Phase 2 |
| Toripalimab | None of these genes | Phase 2 |
| Trametinib | None of these genes | Phase 2 |
| Trastuzumab Deruxtecan | None of these genes | Phase 2 |
| Trastuzumab Emtansine | None of these genes | Phase 2 |
| Trebananib | None of these genes | Phase 2 |
| Tremelimumab | None of these genes | Phase 2 |
| Tretinoin | None of these genes | Phase 2 |
| Trimetrexate | None of these genes | Phase 2 |
| Tyrosine | None of these genes | Phase 2 |
| Uprosertib | None of these genes | Phase 2 |
| Vactosertib | None of these genes | Phase 2 |
| Valproic Acid | None of these genes | Phase 2 |
| Vancomycin | None of these genes | Phase 2 |
| Vandetanib | None of these genes | Phase 2 |
| Vanucizumab | None of these genes | Phase 2 |
| Varlilumab | None of these genes | Phase 2 |
| Vebreltinib | None of these genes | Phase 2 |
| Veliparib | None of these genes | Phase 2 |
| Venetoclax | None of these genes | Phase 2 |
| Vibostolimab | None of these genes | Phase 2 |
| Vicriviroc | None of these genes | Phase 2 |
| Vismodegib | None of these genes | Phase 2 |
| Vitamin E | None of these genes | Phase 2 |
| Volrustomig | None of these genes | Phase 2 |
| Vorbipiprant | None of these genes | Phase 2 |
| Vorinostat | None of these genes | Phase 2 |
| Vudalimab | None of these genes | Phase 2 |
| Xl-999 | None of these genes | Phase 2 |
| Yttrium | None of these genes | Phase 2 |
| Zamaporvint | None of these genes | Phase 2 |
| Zanidatamab | None of these genes | Phase 2 |
| Zd-6126 | None of these genes | Phase 2 |
| Zeprumetostat | None of these genes | Phase 2 |
| Zibotentan | None of these genes | Phase 2 |
| Zongertinib | None of these genes | Phase 2 |
| 2x-121 | None of these genes | Phase 1/2 |
| Amg-820 | None of these genes | Phase 1/2 |
| Amifostine | None of these genes | Phase 1/2 |
| Aminolevulinic Acid | None of these genes | Phase 1/2 |
| Apg-1387 | None of these genes | Phase 1/2 |
| Arsenic Trioxide | None of these genes | Phase 1/2 |
| Avotaciclib | None of these genes | Phase 1/2 |
| Bbp-398 | None of these genes | Phase 1/2 |
| Bempegaldesleukin | None of these genes | Phase 1/2 |
| Bexmarilimab | None of these genes | Phase 1/2 |
| Bintrafusp Alfa | None of these genes | Phase 1/2 |
| Birinapant | None of these genes | Phase 1/2 |
| Bms-754807 | None of these genes | Phase 1/2 |
| Bms-813160 | None of these genes | Phase 1/2 |
| Brivanib Alaninate | None of these genes | Phase 1/2 |
| Brivudine | None of these genes | Phase 1/2 |
| Buparlisib | None of these genes | Phase 1/2 |
| Camptothecin | None of these genes | Phase 1/2 |
| Carfilzomib | None of these genes | Phase 1/2 |
| Cedazuridine | None of these genes | Phase 1/2 |
| Cetrelimab | None of these genes | Phase 1/2 |
| Chembl569766 | None of these genes | Phase 1/2 |
| Copanlisib | None of these genes | Phase 1/2 |
| Cx-5461 | None of these genes | Phase 1/2 |
| Cyc-065 | None of these genes | Phase 1/2 |
| D3s-001 | None of these genes | Phase 1/2 |
| Dacomitinib Anhydrous | None of these genes | Phase 1/2 |
| Darovasertib | None of these genes | Phase 1/2 |
| Dazostinag | None of these genes | Phase 1/2 |
| Digoxin | None of these genes | Phase 1/2 |
| Dordaviprone | None of these genes | Phase 1/2 |
| Dupilumab | None of these genes | Phase 1/2 |
| Duvelisib | None of these genes | Phase 1/2 |
| E-7386 | None of these genes | Phase 1/2 |
| Eltanexor | None of these genes | Phase 1/2 |
| Emidurdar | None of these genes | Phase 1/2 |
| Enadenotucirev | None of these genes | Phase 1/2 |
| Epacadostat | None of these genes | Phase 1/2 |
| Ergocalciferol | None of these genes | Phase 1/2 |
| Etaracizumab | None of these genes | Phase 1/2 |
| Etrumadenant | None of these genes | Phase 1/2 |
| Flucytosine | None of these genes | Phase 1/2 |
| Fulvestrant | None of these genes | Phase 1/2 |
| Galinpepimut-S | None of these genes | Phase 1/2 |
| Galunisertib | None of these genes | Phase 1/2 |
| Ganitumab | None of these genes | Phase 1/2 |
| Garsorasib | None of these genes | Phase 1/2 |
| Gc1118 | None of these genes | Phase 1/2 |
| Glecirasib | None of these genes | Phase 1/2 |
| Glycerol Phenylbutyrate | None of these genes | Phase 1/2 |
| Guadecitabine | None of these genes | Phase 1/2 |
| Gumarontinib | None of these genes | Phase 1/2 |
| Hyaluronidase (Human Recombinant) | None of these genes | Phase 1/2 |
| Ibrutinib | None of these genes | Phase 1/2 |
| Idasanutlin | TP53 | Phase 1/2 |
| Ifebemtinib | None of these genes | Phase 1/2 |
| Ifinatamab Deruxtecan | None of these genes | Phase 1/2 |
| Imiquimod | None of these genes | Phase 1/2 |
| Inbakicept | None of these genes | Phase 1/2 |
| Incomplete Freund'S Adjuvant | None of these genes | Phase 1/2 |
| Indomethacin | None of these genes | Phase 1/2 |
| Interferon | None of these genes | Phase 1/2 |
| Interferon Gamma-1b | None of these genes | Phase 1/2 |
| Irinotecan Sucrosofate | None of these genes | Phase 1/2 |
| Isatuximab | None of these genes | Phase 1/2 |
| Ivuxolimab | None of these genes | Phase 1/2 |
| Izeltabart Tapatansine | None of these genes | Phase 1/2 |
| Izorlisib | None of these genes | Phase 1/2 |
| Krn-330 | None of these genes | Phase 1/2 |
| L19tnfa | None of these genes | Phase 1/2 |
| Lutetium Lu177 Edotreotide | None of these genes | Phase 1/2 |
| Lutetium Lu 177 Zadavotide Guraxetan | None of these genes | Phase 1/2 |
| Lutetium Oxodotreotide | None of these genes | Phase 1/2 |
| Ly-3200882 | None of these genes | Phase 1/2 |
| Mgd-007 | None of these genes | Phase 1/2 |
| Mirdametinib | None of these genes | Phase 1/2 |
| Nelmastobart | None of these genes | Phase 1/2 |
| Neratinib | None of these genes | Phase 1/2 |
| Nidanilimab | None of these genes | Phase 1/2 |
| Nogapendekin Alfa | None of these genes | Phase 1/2 |
| Oblimersen Sodium | None of these genes | Phase 1/2 |
| Olaptesed Pegol | None of these genes | Phase 1/2 |
| Olinvacimab | None of these genes | Phase 1/2 |
| Omega-3-Acid Ethyl Esters | None of these genes | Phase 1/2 |
| Pasifolate Exatecan | None of these genes | Phase 1/2 |
| Pegargiminase | None of these genes | Phase 1/2 |
| Phenylbutanoic Acid | None of these genes | Phase 1/2 |
| Plicamycin | None of these genes | Phase 1/2 |
| Quemliclustat | None of these genes | Phase 1/2 |
| Refametinib | None of these genes | Phase 1/2 |
| Retifanlimab | None of these genes | Phase 1/2 |
| Revumenib | None of these genes | Phase 1/2 |
| Rilotumumab | None of these genes | Phase 1/2 |
| Rucaparib | None of these genes | Phase 1/2 |
| Sabatolimab | None of these genes | Phase 1/2 |
| Selicrelumab | None of these genes | Phase 1/2 |
| Sirolimus | None of these genes | Phase 1/2 |
| Sitagliptin | None of these genes | Phase 1/2 |
| Solnerstotug | None of these genes | Phase 1/2 |
| Sonolisib | None of these genes | Phase 1/2 |
| Sra-737 | None of these genes | Phase 1/2 |
| Subasumstat | None of these genes | Phase 1/2 |
| Sulfur Hexafluoride | None of these genes | Phase 1/2 |
| Sx-682 | None of these genes | Phase 1/2 |
| Tak-186 | None of these genes | Phase 1/2 |
| Telaglenastat | None of these genes | Phase 1/2 |
| Temuterkib | None of these genes | Phase 1/2 |
| Troculeucel | None of these genes | Phase 1/2 |
| Umikibart | None of these genes | Phase 1/2 |
| Urelumab | None of these genes | Phase 1/2 |
| Utomilumab | None of these genes | Phase 1/2 |
| Vilamakitug | None of these genes | Phase 1/2 |
| Vipivotide Tetraxetan Lutetium | None of these genes | Phase 1/2 |
| Wnt-974 | None of these genes | Phase 1/2 |
| Xl-281 | None of these genes | Phase 1/2 |
| Xp-102 | None of these genes | Phase 1/2 |
| Zalutumumab | None of these genes | Phase 1/2 |
| Zimberelimab | None of these genes | Phase 1/2 |
| 1018 Iss | None of these genes | Phase 1 |
| A33 131i | None of these genes | Phase 1 |
| Abgn-107 | None of these genes | Phase 1 |
| Adakitug | None of these genes | Phase 1 |
| Adavosertib | None of these genes | Phase 1 |
| Alextatug | None of these genes | Phase 1 |
| Alisertib | None of these genes | Phase 1 |
| Amp-224 | None of these genes | Phase 1 |
| Andecaliximab | None of these genes | Phase 1 |
| Apl-501 | None of these genes | Phase 1 |
| Apomab | None of these genes | Phase 1 |
| Ascrinvacumab | None of these genes | Phase 1 |
| Asn007 | None of these genes | Phase 1 |
| Asp-1951 | None of these genes | Phase 1 |
| Atorvastatin | None of these genes | Phase 1 |
| Azd-0156 | None of these genes | Phase 1 |
| Azenosertib | None of these genes | Phase 1 |
| Batoprotafib | None of these genes | Phase 1 |
| Bemcentinib | None of these genes | Phase 1 |
| Bms-986299 | None of these genes | Phase 1 |
| Brontictuzumab | None of these genes | Phase 1 |
| Budigalimab | None of these genes | Phase 1 |
| C-188-9 | None of these genes | Phase 1 |
| Canagliflozin Anhydrous | None of these genes | Phase 1 |
| Canakinumab | None of these genes | Phase 1 |
| Capmatinib | None of these genes | Phase 1 |
| Cb-5083 | None of these genes | Phase 1 |
| Cbp-501 | None of these genes | Phase 1 |
| Cenisertib | None of these genes | Phase 1 |
| Ceralasertib | None of these genes | Phase 1 |
| Cjm-112 | None of these genes | Phase 1 |
| Claturafenib | None of these genes | Phase 1 |
| Dactolisib | None of these genes | Phase 1 |
| Demcizumab | None of these genes | Phase 1 |
| Diazepinomicin | None of these genes | Phase 1 |
| Divarasib | None of these genes | Phase 1 |
| Drozitumab | None of these genes | Phase 1 |
| Ds-7423 | None of these genes | Phase 1 |
| Ds-8273a | None of these genes | Phase 1 |
| Dulanermin | None of these genes | Phase 1 |
| E-7766 | None of these genes | Phase 1 |
| Elimusertib | None of these genes | Phase 1 |
| Emavusertib | None of these genes | Phase 1 |
| Emd-1201081 | None of these genes | Phase 1 |
| Enmd-2076 | None of these genes | Phase 1 |
| Ezabenlimab | None of these genes | Phase 1 |
| F19 131i | None of these genes | Phase 1 |
| Fapi Ga-68 | None of these genes | Phase 1 |
| Finotonlimab | None of these genes | Phase 1 |
| Fludarabine Phosphate | None of these genes | Phase 1 |
| Fluoxetine | None of these genes | Phase 1 |
| Gatipotuzumab | None of these genes | Phase 1 |
| Gevokizumab | None of these genes | Phase 1 |
| Gozetotide | None of these genes | Phase 1 |
| Grapiprant | None of these genes | Phase 1 |
| Gti-2040 | None of these genes | Phase 1 |
| Guselkumab | None of these genes | Phase 1 |
| Hua33 | None of these genes | Phase 1 |
| Hydroxytyrosol | None of these genes | Phase 1 |
| Icovamenib | None of these genes | Phase 1 |
| Imc-3c5 | None of these genes | Phase 1 |
| Istiratumab | None of these genes | Phase 1 |
| Itacitinib | None of these genes | Phase 1 |
| Lapachone | None of these genes | Phase 1 |
| Lb-100 | None of these genes | Phase 1 |
| Linsitinib | None of these genes | Phase 1 |
| Lithium | None of these genes | Phase 1 |
| Luminespib | None of these genes | Phase 1 |
| Lurbinectedin | None of these genes | Phase 1 |
| Maraviroc | None of these genes | Phase 1 |
| Me-344 | None of these genes | Phase 1 |
| Medi-6469 | None of these genes | Phase 1 |
| Merestinib | None of these genes | Phase 1 |
| Midostaurin | None of these genes | Phase 1 |
| Migoprotafib | None of these genes | Phase 1 |
| Mk-0752 | None of these genes | Phase 1 |
| Mk-8353 | None of these genes | Phase 1 |
| Ml-246 | None of these genes | Phase 1 |
| Motesanib | None of these genes | Phase 1 |
| Mvt-5873 | None of these genes | Phase 1 |
| Naporafenib | None of these genes | Phase 1 |
| Naptumomab Estafenatox | None of these genes | Phase 1 |
| Nazartinib | None of these genes | Phase 1 |
| Nilotinib | None of these genes | Phase 1 |
| Numidargistat | None of these genes | Phase 1 |
| Ob-002 | None of these genes | Phase 1 |
| Onalespib | None of these genes | Phase 1 |
| Onvatilimab | None of these genes | Phase 1 |
| Osi-7904 | None of these genes | Phase 1 |
| Osimertinib | None of these genes | Phase 1 |
| Paclitaxel Poliglumex | None of these genes | Phase 1 |
| Parsaclisib | None of these genes | Phase 1 |
| Pazopanib | None of these genes | Phase 1 |
| Pegilodecakin | None of these genes | Phase 1 |
| Pemvidutide | None of these genes | Phase 1 |
| Pepinemab | None of these genes | Phase 1 |
| Pexidartinib | None of these genes | Phase 1 |
| Pf-06671008 | None of these genes | Phase 1 |
| Pki-179 | None of these genes | Phase 1 |
| Platinum | None of these genes | Phase 1 |
| Ponsegromab | None of these genes | Phase 1 |
| Pralatrexate | None of these genes | Phase 1 |
| Prexasertib | None of these genes | Phase 1 |
| Ribociclib | None of these genes | Phase 1 |
| Ridaforolimus | None of these genes | Phase 1 |
| Riluzole | None of these genes | Phase 1 |
| Rimiducid | None of these genes | Phase 1 |
| Ropeginterferon Alfa-2b | None of these genes | Phase 1 |
| Rosmantuzumab | None of these genes | Phase 1 |
| Samotolisib | None of these genes | Phase 1 |
| Sapanisertib | None of these genes | Phase 1 |
| Sasanlimab | None of these genes | Phase 1 |
| Sc-006 | None of these genes | Phase 1 |
| Sc-007 | None of these genes | Phase 1 |
| Silibinin | None of these genes | Phase 1 |
| Simmitecan | None of these genes | Phase 1 |
| Sinecatechins | None of these genes | Phase 1 |
| Siremadlin | TP53 | Phase 1 |
| Sodium Iodide | None of these genes | Phase 1 |
| Sonidegib | None of these genes | Phase 1 |
| Streptozocin | None of these genes | Phase 1 |
| Sy-5609 | None of these genes | Phase 1 |
| Talimogene Laherparepvec | None of these genes | Phase 1 |
| Taurursodiol | None of these genes | Phase 1 |
| Tb-403 | None of these genes | Phase 1 |
| Tenatumomab | None of these genes | Phase 1 |
| Thrombomodulin Alfa | None of these genes | Phase 1 |
| Tilsotolimod | None of these genes | Phase 1 |
| Tocladesine | None of these genes | Phase 1 |
| Tomuzotuximab | None of these genes | Phase 1 |
| Tositumomab | None of these genes | Phase 1 |
| Tozasertib | None of these genes | Phase 1 |
| Tucotuzumab Celmoleukin | None of these genes | Phase 1 |
| Tusamitamab Ravtansine | None of these genes | Phase 1 |
| Tuxobertinib | None of these genes | Phase 1 |
| Ulixertinib | None of these genes | Phase 1 |
| Ursodiol | None of these genes | Phase 1 |
| Vincristine | None of these genes | Phase 1 |
| Vinorelbine | None of these genes | Phase 1 |
| Vociprotafib | None of these genes | Phase 1 |
| Vsv-Gp128 | None of these genes | Phase 1 |
| Xevinapant | None of these genes | Phase 1 |
| Zelenirstat | None of these genes | Phase 1 |
| Zen-3694 | None of these genes | Phase 1 |
| Zotiraciclib | None of these genes | Phase 1 |
| Inulin | None of these genes | Early phase 1 |
| Montelukast | None of these genes | Early phase 1 |
| Cct251545 | None of these genes | Preclinical |
| Bupivacaine | None of these genes | Unknown |
| Dexmedetomidine | None of these genes | Unknown |
| Elobixibat | None of these genes | Unknown |
| Fentanyl | None of these genes | Unknown |
| Ibuprofen | None of these genes | Unknown |
| Icosapent | None of these genes | Unknown |
| Ketamine | None of these genes | Unknown |
| Ketorolac | None of these genes | Unknown |
| Magnesium | None of these genes | Unknown |
| Nacolomab Tafenatox | None of these genes | Unknown |
| Ondansetron | None of these genes | Unknown |
| Potassium Chloride | None of these genes | Unknown |
| Remifentanil | None of these genes | Unknown |
| Rocuronium | None of these genes | Unknown |
| Sodium Ascorbate | None of these genes | Unknown |
| Sodium Chloride | None of these genes | Unknown |
| Sodium Sulfate Anhydrous | None of these genes | Unknown |
| Sufentanil | None of these genes | Unknown |
| Sugammadex | None of these genes | Unknown |
| Testosterone | None of these genes | Unknown |
| Tozinameran | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.